SCHEMBL1035210

SCHEMBL1035210

Cc1noc(NC(=O)N2CCC(=Cc3cccc(OCCC(C)C)c3)C(C)C2)c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR3 O60755 1/20 0.35
HSP90AA1 P07900 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
OGA O60502 1/20 0.33
KMT2A Q03164 5/20 0.33
MEN1 O00255 4/20 0.33
SLC5A1 P13866 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ENPP2 Q13822 1/20 0.33
POLB P06746 2/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
FAAH O00519 2/20 0.32
GABRA1 P14867 1/20 0.32
ADRA2C P18825 1/20 0.32
CNR1 P21554 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1035209 1.00 GALR3 (0.35) GALR3HSP90AA1NR1H4CYP3A4CYP2D6
SCHEMBL1035914 0.92 CYP3A4 (0.33) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1035916 0.92 CYP3A4 (0.33) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1033123 0.92 GSK3B (0.37) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1033125 0.92 GSK3B (0.37) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1035469 0.92 NPSR1 (0.36) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1035470 0.92 NPSR1 (0.36) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1035486 0.90 CYP3A4 (0.34) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1035489 0.90 CYP3A4 (0.34) CYP3A4CYP2D6OGAKMT2AMEN1
SCHEMBL1037122 0.89 ENPP2 (0.38) KMT2AMEN1MAPK1HSD17B10ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2011-03-03 US claimed
EP-2276738-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS Pfizer Inc. (US) 2011-01-26 EP claimed
WO-2009127943-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2009-10-22 WO claimed
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2011-03-03 US disclosed
EP-2276738-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS Pfizer Inc. (US) 2011-01-26 EP disclosed
WO-2009127943-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2009-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053982-A1 ETHER BENZYLIDENE PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS FAAH, FAAH2, CNR2 GALR3 761/4885HSP90AA1 1659/4885NR1H4 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.